摘要
目的:观察耳泌泰方治疗急性分泌性中耳炎的临床疗效。方法:选取符合纳入标准的80例患者随机分为2组。治疗组用耳泌泰方(组成:桑白皮、葶苈子、柴胡、黄芩、辛夷等)治疗,对照组口服沐舒坦。观测2组治疗前后临床症状、体征、纯音听阈、咽鼓管功能、鼓室导抗图等的变化情况。结果:总有效率治疗组为80.0%,对照组为67.5%,2组临床疗效比较,差异有显著性意义(P<0.05),治疗组疗效优于对照组。治疗组治疗后听力明显提高,与对照组比较,差异有显著性意义(P<0.05)。表明耳泌泰可以明显改善患者听力。治疗组治疗后咽鼓管功能明显改善,与对照组比较,差异有显著性意义(P<0.05)。表明耳泌泰可明显改善咽鼓管功能,有效缓解患者耳闷堵感等症状。治疗组治疗后鼓室图明显改善,与对照组比较,差异有显著性意义(P<0.05)。表明耳泌泰能有效改善中耳功能。结论:耳泌泰方治疗急性分泌性中耳炎临床疗效肯定。
Objective:To observe the therapeutic effect of Ermitai Prescription (EP) for acute secretory otitis media(ASOM).Methods:Eighty qualified ASOM patients were equally randomized into 2 groups:the treatment group received EP (mainly composed of Cortex Mori,Semen Lepidii seu Descurainiae,Radix Bupleuri, Radix Scutellariae,Flos Magnoliae,etc),and the control group received Mucosolvin. The changes of clinical symptoms and signs,pure tone audibility threshold, eustachian tube function,and tympanogram were observed before and after treatment. Results:The total effective rate was 80.0%in the treatment group and 67.5%in the control group,the difference being significant between the two groups(P<0.05) The improvement of hearing,eustachian tube function,and tympanogram in the treatment group was superior to that in the control group after treatment(P<0.05), indicating that EP had a better effect on improving hearing,relieving auricular stuffiness and middle ear function.Conclusion:Ermitai Prescription has certain effect for the treatment of ASOM.
出处
《新中医》
CAS
北大核心
2010年第1期25-26,共2页
New Chinese Medicine
